Health TrialsbyHealthPanel

The Effectiveness of Virtual Reality Training Program

ConditionAlzheimer Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-90
SponsorYeditepe University

About this trial

Alzheimer's disease is the most common type of dementia, accounting for 50% of all cases. Advanced age is a significant risk factor for AD. Virtual Reality (VR) is an interactive video game technology that provides computer-generated environments that include physical activity and provide users with experiences similar to those in the real world. VR technology can be used for rehabilitation purposes in individuals with various orthopedic and neurological disorders due to its ability to enhance motor, cognitive learning and neural plasticity (1,2). The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

≥ 55 years and older Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist, MOCA ≥ 16 Clinical Dementia Rating Scale < 2

Disqualifiers

Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.) Clinically significant aphasia (must be able to understand the therapist's commands) Significant visual or sensory impairment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual reality training

    Device

    Virtual reality training

  • Conventional exercise and cognitive exercise

    Other intervention

    Conventional exercise and cognitive exercise

  • control

    Other intervention

    no intervention

Treatment groups

45 Participants
are divided into 3 treatment groups
Group A: Virtual reality training groupExperimental treatment 2 interventions
Group B: Conventional exercise and cognitive exercise groupExperimental treatment 2 interventions
Group C: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Montreal cognitive assessment scale

MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment.

Time frame
12 weeks
2

Berg Balance Scale

BBS measures static and dynamic balance in elderly individuals

Time frame
12 weeks
3

Time up and Go Test

TUG test evaluates fall risk, mobility and physical performance in the elderly

Time frame
12 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yeditepe University

Lead sponsor

Source ClinicalTrials.gov
Apply now